These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19461893)

  • 21. Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer.
    Zhang D; Lin K; Lu Y; Rycaj K; Zhong Y; Chao HP; Calhoun-Davis T; Shen J; Tang DG
    Stem Cells Transl Med; 2017 Mar; 6(3):748-760. PubMed ID: 28297567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse model.
    Fan X; Bjerke GA; Riemondy K; Wang L; Yi R
    Mol Carcinog; 2019 Dec; 58(12):2241-2253. PubMed ID: 31512783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model.
    Mulholland DJ; Xin L; Morim A; Lawson D; Witte O; Wu H
    Cancer Res; 2009 Nov; 69(22):8555-62. PubMed ID: 19887604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.
    Martin P; Liu YN; Pierce R; Abou-Kheir W; Casey O; Seng V; Camacho D; Simpson RM; Kelly K
    Am J Pathol; 2011 Jul; 179(1):422-35. PubMed ID: 21703421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors.
    Agarwal S; Hynes PG; Tillman HS; Lake R; Abou-Kheir WG; Fang L; Casey OM; Ameri AH; Martin PL; Yin JJ; Iaquinta PJ; Karthaus WR; Clevers HC; Sawyers CL; Kelly K
    Cell Rep; 2015 Dec; 13(10):2147-58. PubMed ID: 26628377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A luminal epithelial stem cell that is a cell of origin for prostate cancer.
    Wang X; Kruithof-de Julio M; Economides KD; Walker D; Yu H; Halili MV; Hu YP; Price SM; Abate-Shen C; Shen MM
    Nature; 2009 Sep; 461(7263):495-500. PubMed ID: 19741607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
    Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR
    PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
    Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
    Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vitro system to characterize prostate cancer progression identified signaling required for self-renewal.
    Salah M; Nishimoto Y; Kohno S; Kondoh A; Kitajima S; Muranaka H; Nishiuchi T; Ibrahim A; Yoshida A; Takahashi C
    Mol Carcinog; 2016 Dec; 55(12):1974-1989. PubMed ID: 26621780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIM28 promotes luminal cell plasticity in a mouse model of prostate cancer.
    Yende AS; Williams EC; Pletcher A; Helfand A; Ibeawuchi H; North TM; Latham PS; Horvath A; Shibata M
    Oncogene; 2023 Apr; 42(17):1347-1359. PubMed ID: 36882525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential requirements for β-catenin in murine prostate cancer originating from basal versus luminal cells.
    Lu TL; Chen CM
    J Pathol; 2015 Jul; 236(3):290-301. PubMed ID: 25712462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
    Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
    Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate.
    Fang X; Gyabaah K; Nickkholgh B; Cline JM; Balaji KC
    Prostate; 2015 Jun; 75(9):988-1000. PubMed ID: 25753731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
    Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers.
    Bonkhoff H; Stein U; Remberger K
    Hum Pathol; 1994 Jan; 25(1):42-6. PubMed ID: 7508883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Runx2 in prostate development and stem cell function.
    Li Y; Ge C; Franceschi RT
    Prostate; 2021 Mar; 81(4):231-241. PubMed ID: 33411419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Sca-1
    Kwon OJ; Choi JM; Zhang L; Jia D; Li Z; Zhang Y; Jung SY; Creighton CJ; Xin L
    Stem Cells; 2020 Nov; 38(11):1479-1491. PubMed ID: 32627901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.
    Timofeeva OA; Palechor-Ceron N; Li G; Yuan H; Krawczyk E; Zhong X; Liu G; Upadhyay G; Dakic A; Yu S; Fang S; Choudhury S; Zhang X; Ju A; Lee MS; Dan HC; Ji Y; Hou Y; Zheng YL; Albanese C; Rhim J; Schlegel R; Dritschilo A; Liu X
    Oncotarget; 2017 Apr; 8(14):22741-22758. PubMed ID: 28009986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.
    Kelavkar UP; Parwani AV; Shappell SB; Martin WD
    Neoplasia; 2006 Jun; 8(6):510-22. PubMed ID: 16820097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.
    Wang S; Garcia AJ; Wu M; Lawson DA; Witte ON; Wu H
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1480-5. PubMed ID: 16432235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.